Pharma

Your Article Summary

See Latest Articles

Medtronic Announces U.S. Trial of Unique Therapy for Closure of the Left Atrial Appendage
Medtronic, 05/11/09

Medtronic, Inc. announced the successful implant of its Cardioblate Closure Left Atrial Appendage Occlusion Device by Dr. Patrick McCarthy, co-director of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital in Chicago, Ill., as part of a U.S. clinical trial. The study is being conducted under an Investigational Device Exemption (IDE) and the device is limited to investigational use in the United States.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Annual Progression of Coronary Calcification in Trials of Preventive Therapies
Archives of Internal Medicine, 12/14/09

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years
The Lancet, 12/14/09

Short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on surgical site infection and methicillin-resistant Staphylococcus aureus infection in elective colon cancer surgery: Results of a prospective randomized trial
Surgery Today, 12/14/09

 See all of Drug Trials

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09

Greater chances of cure for patients with HER2-positive early breast cancer when treated with one year of Herceptin
Roche, 12/14/09

Sanofi-aventis doubles syringe production capacity and diversifies vaccine production at the Le Trait Manufacturing Plant
Sanofi-aventis, 12/14/09

 See all of Medical Devices/Products